Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Braeburn's Buprenorphine Bid: Eight Dosing Options Part Of "All Hands On Deck" Approach

Executive Summary

With an FDA decision on its buprenorphine injection expected by Jan. 19, Scrip spoke with Braeburn executives at J.P. Morgan about the company's justification for four once-weekly and four once-monthly doses, competition in the opioid use disorder (OUD) market and the need for more OUD therapies.

Advertisement

Related Content

While You Were Out: News In Brief
Indivior's Once-Monthly Buprenorphine Clears US FDA With Box Warning, REMS
Opioid Treatments Could Get Survival Claim As US FDA Develops Protocol
Dual Injection Approvals? A Comparison Of Indivior, Braeburn Buprenorphine Products
Braeburn's Buprenorphine Candidate Faces Safety Gauntlet At US FDA Panel
Declaring Opioid Emergency, Trump Touts FDA Actions, NIH-Industry Partnerships
US IPOs In Review: Relatively Muted Market In 2016 To Continue In 2017

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel